| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |